Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
First-in-Human Study of Oleclumab, a Potent, Selective Anti-CD73 Monoclonal Antibody, Alone or in Combination With Durvalumab in Patients With Advanced Solid Tumors, Johanna Bendell, Patricia LoRusso, Michael Overman, et al.
Circadian Features of Cluster Headache and Migraine: A Systematic Review, Meta-Analysis, and Genetic Analysis, Barlas Benkli, Sun Young Kim, Nobuya Koike, et al.
Risk of Early Death in Adolescents and Young Adults With Cancer: A Population-Based Study, Amy M Berkman, Clark R Andersen, Michelle A T Hildebrandt, et al.
Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial, Donald A Berry, Shobha Dhadda, Michio Kanekiyo, et al.
Antibodies to Coagulase of Staphylococcus aureus Crossreact to Efb and Reveal Different Binding of Shared Fibrinogen Binding Repeats, Federico Bertoglio, Ya-Ping Ko, Sheila Thomas, et al.
Exceptional Responses to Selpercatinib in RET-fusion driven Metastatic Pancreatic Cancer, Deepak Bhamidipati, Sireesha Yedururi, Jason Huse, et al.
Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon Cancer Cells, Nobel Bhasin, Prerna Dabral, Lakmini Senavirathna, et al.
Isoform-Level Transcriptome-Wide Association Uncovers Genetic Risk Mechanisms for Neuropsychiatric Disorders in the Human Brain, Arjun Bhattacharya, Daniel D Vo, Connor Jops, et al.
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia, Seemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia, Seemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.
Phenotypic Maps for Precision Medicine: A Promising Systems Biology Tool for Assessing Therapy Response and Resistance at a Personalized Level, Sayantan Bhattacharyya, Shafqat F Ehsan, and Loukia G Karacosta
A Heritable Iron Memory Enables Decision-Making in Escherichia coli, Souvik Bhattacharyya, Nabin Bhattarai, Dylan M Pfannenstiel, et al.
A Case of Successful Treatment of Recurrent Urinary Tract infection By Extended-Spectrum Β-Lactamase Producing, Naomi Bier, Blake Hanson, Zhi-Dong Jiang, et al.
A Case of Successful Treatment of Recurrent Urinary Tract Infection by Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Using Oral Lyophilized Fecal Microbiota Transplant, Naomi Bier, Blake Hanson, Zhi-Dong Jiang, et al.
C4b-Binding Protein Inhibits Particulate- and Crystalline-Induced NLRP3 Inflammasome Activation, Damien Bierschenk, Nikolina Papac-Milicevic, Ian P Bresch, et al.
Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel, David G Birch, Janet K Cheetham, Stephen P Daiger, et al.
Induction of Thrombotic Thrombocytopenic Purpura by Dengue Virus Infection in a Critical Patient: Role of Therapeutic Plasma Exchange, Rathindra Nath Biswas, Sudipta Sekhar Das, Anupam Chakrapani, et al.
Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence-Ready Informatics Ecosystem for Radiation Oncology, Danielle S Bitterman, Michael F Gensheimer, David Jaffray, et al.
Animal Models in Systemic Sclerosis: An Update, Xiongjie Bi, Tingting Mills, and Minghua Wu
The New World of RNA Diagnostics and Therapeutics, Giovanni Blandino, Roberto Dinami, Marco Marcia, et al.
Clinically Stable COVID-19 Patients Presenting to Acute Unscheduled Episodic Care Venues Have Increased Risk of Hospitalization: Secondary Analysis of a Randomized Control Trial, Joseph Bledsoe, Scott C Woller, Maria Brooks, et al.
Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections, Andrew Bock, Blake M Hanson, Felicia Ruffin, et al.
A Phase 1 Study to Evaluate the Safety, Pharmacology, and Feasibility of Continuous Infusion Nelarabine in Patients With Relapsed and/or Refractory Lymphoid Malignancies, Prajwal C Boddu, Jayastu Senapati, Farhad Ravandi-Kashani, et al.
An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye, Sai H S Boddu, Devarshi Acharya, Vivek Hala, et al.
Cancer Survivors’ Health Behaviors and Outcomes: A Population-Based Study of Sexual and Gender Minorities, Ulrike Boehmer, Shine Chang, Nelson F Sanchez, et al.